Form D · Biotechnology
SEQUENOM INC
San Diego, X1 · CIK 0001076481
Offering snapshot reported Jun 19, 2015 · SEC filing
- Reported sold
- $85M Offering amount: $85M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 9, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 19, 2015 | Initial | $85,000,000 | No comparison | 10 | SEC filing |
| Sep 24, 2012 | Initial | $130,000,000 | No comparison | 2 | SEC filing |
| May 24, 2010 | Initial | $51,605,250 | No comparison | 18 | SEC filing |
| Dec 29, 2009 | Initial | $1,512,015 | No comparison | 27 | SEC filing |
| Mar 12, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 28, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 9, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 16, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 23, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $1.49M (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-242128
Represents the aggregate principal amount of 5.00% Convertible Exchange Senior Notes due 2018, which were exchanged for existing notes in the same amount.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Lazard Feres & Co. | 2528 |
Source: Form D, filed Jun 19, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ernst Gunter Afting | Director |
| Carolyn Beaver | Executive |
| Allen T. Bombard | Executive |
| Kenneth F. Buechler | Director |
| Charles R. Cantor | Executive |
| John A. Fazio | Director |
| Daniel S. Grosu | Executive |
| Harry F. Hixson | Director, Executive |
| Alisa Judge | Executive |
| Myla Lai Goldman | Director |
| Richard A. Lerner | Director |
| Ronald M. Lindsay | Director |
| Jeff Linton | Executive |
| Paul Maier | Executive |
| Shawn Marcell | Executive |
| Alexander Monko | Executive |
| Larry Myres | Executive |
| Clarke Neumann | Executive |
| David Pendarvis | Director |
| Gary Riordan | Executive |
| Charles Slacik | Director |
| Dirk Van Den Boom | Director, Executive |
| Robin Weiner | Executive |
| William Welch | Director, Executive |
| Kathleen W. Wiltsey | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3595 John Hopkins Court
San Diego, X1, 92121
San Diego, X1, 92121